GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pure Extracts Technologies Corp (FRA:PUX) » Definitions » EBITDA Margin %

Pure Extracts Technologies (FRA:PUX) EBITDA Margin % : -78.60% (As of Mar. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Pure Extracts Technologies EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Pure Extracts Technologies's EBITDA for the three months ended in Mar. 2023 was €-0.37 Mil. Pure Extracts Technologies's Revenue for the three months ended in Mar. 2023 was €0.47 Mil. Therefore, Pure Extracts Technologies's EBITDA margin for the quarter that ended in Mar. 2023 was -78.60%.


Pure Extracts Technologies EBITDA Margin % Historical Data

The historical data trend for Pure Extracts Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pure Extracts Technologies EBITDA Margin % Chart

Pure Extracts Technologies Annual Data
Trend Jun21 Jun22
EBITDA Margin %
-19,491.30 -353.19

Pure Extracts Technologies Quarterly Data
Sep19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -723.08 -288.97 -70.87 -135.71 -78.60

Competitive Comparison of Pure Extracts Technologies's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Pure Extracts Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pure Extracts Technologies's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pure Extracts Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Pure Extracts Technologies's EBITDA Margin % falls into.



Pure Extracts Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Pure Extracts Technologies's EBITDA Margin % for the fiscal year that ended in Jun. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2022 )/Revenue (A: Jun. 2022 )
=-3.207/0.908
=-353.19 %

Pure Extracts Technologies's EBITDA Margin % for the quarter that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2023 )/Revenue (Q: Mar. 2023 )
=-0.371/0.472
=-78.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pure Extracts Technologies  (FRA:PUX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Pure Extracts Technologies EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Pure Extracts Technologies's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pure Extracts Technologies (FRA:PUX) Business Description

Traded in Other Exchanges
N/A
Address
7341 Industrial Way, Unit 6, Pemberton, BC, CAN, V0N 2K0
Pure Extracts Technologies Corp is a plant-based extraction company. The company specializes in the processing of cannabis, hemp and functional mushrooms to produce oils and various derivative products. Also, the company is involved in white labelling activities as well as selling branded oil-based products. It has three operating segments, the extraction and processing of cannabis and hemp, the development and commercialization of functional wellness products including psychedelic medicinal products, and its head office.

Pure Extracts Technologies (FRA:PUX) Headlines

No Headlines